Globus Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	12,911	11,685	11,262	7,343	7,415	7,326
Market Cap Growth	12.50%	3.76%	53.38%	-0.97%	1.22%	13.84%
Enterprise Value	12,402	11,398	11,092	7,122	6,506	6,347
Last Close Price	95.46	87.31	82.71	53.29	74.27	72.20
PE Ratio	24.35	21.73	109.36	59.76	38.99	49.11
Forward PE	21.40	21.59	25.54	20.76	32.74	33.48
PS Ratio	4.39	3.98	4.47	4.68	7.25	7.65
PB Ratio	2.82	2.56	2.70	1.84	4.02	4.21
P/TBV Ratio	5.40	4.88	5.78	4.48	4.68	4.91
P/FCF Ratio	21.93	19.85	27.79	44.44	71.01	33.40
P/OCF Ratio	17.14	15.51	21.63	30.16	41.55	26.52
PEG Ratio	2.23	1.51	1.82	1.81	2.71	3.26
EV/Sales Ratio	4.22	3.88	4.40	4.54	6.36	6.62
EV/EBITDA Ratio	14.14	13.00	15.97	17.00	21.30	23.97
EV/EBIT Ratio	20.66	18.99	25.15	26.04	27.44	32.57
EV/FCF Ratio	21.06	19.36	27.37	43.11	62.31	28.93
Debt / Equity Ratio	0.03	0.03	0.13	0.13	0.00	-
Debt / EBITDA Ratio	0.13	0.13	0.75	1.19	0.02	-
Debt / FCF Ratio	0.20	0.20	1.33	3.16	0.06	-
Net Debt / Equity Ratio	-0.11	-0.11	-0.10	-0.02	-0.51	-0.58
Net Debt / EBITDA Ratio	-0.58	-0.58	-0.60	-0.17	-3.06	-3.80
Net Debt / FCF Ratio	-0.87	-0.87	-1.03	-0.44	-8.96	-4.58
Asset Turnover	0.56	0.56	0.49	0.44	0.51	0.53
Inventory Turnover	1.32	1.32	1.09	0.83	0.98	1.03
Quick Ratio	2.61	2.61	1.72	2.61	4.17	4.35
Current Ratio	4.26	4.26	2.54	4.88	6.18	6.17
Return on Equity (ROE)	12.29%	12.29%	2.52%	4.21%	10.60%	9.19%
Return on Assets (ROA)	7.11%	7.11%	5.33%	4.77%	7.35%	6.70%
Return on Invested Capital (ROIC)	12.91%	13.41%	9.61%	7.51%	13.69%	13.53%
Return on Capital Employed (ROCE)	12.50%	12.50%	10.00%	5.80%	12.40%	10.70%
Earnings Yield	4.17%	4.60%	0.91%	1.67%	2.56%	2.04%
FCF Yield	4.56%	5.04%	3.60%	2.25%	1.41%	2.99%
Buyback Yield / Dilution	0.58%	0.58%	-20.27%	-11.68%	0.95%	-2.63%

Updated Feb 24, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q